Up­dat­ed: Dai­ichi Sankyo to es­tab­lish Japan's first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty — re­port

Dai­ichi Sankyo is look­ing to es­tab­lish a man­u­fac­tur­ing ap­pa­ra­tus close to home to be­gin pro­duc­ing the first made-in-Japan mR­NA Covid vac­cines.

Ac­cord­ing to a re­port from Nikkei Asia, Dai­ichi Sankyo is in­stalling equip­ment that will have the ca­pac­i­ty to pro­duce 20 mil­lion dos­es a year by the fis­cal year 2024. The re­port says that equip­ment has been in­stalled at a lo­ca­tion in the city of Ki­ta­mo­to, Japan, north­east of Tokyo, and is op­er­at­ed by the sub­sidiary Dai­ichi Sankyo Biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER